2023
DOI: 10.1021/acschembio.3c00028
|View full text |Cite
|
Sign up to set email alerts
|

Genetically Encoded Aminocoumarin Lysine for Optical Control of Protein–Nucleotide Interactions in Zebrafish Embryos

Abstract: The strategic placement of unnatural amino acids into the active site of kinases and phosphatases has allowed for the generation of photocaged signaling proteins that offer spatiotemporal control over activation of these pathways through precise light exposure. However, deploying this technology to study cell signaling in the context of embryo development has been limited. The promise of optical control is especially useful in the early stages of an embryo where development is driven by tightly orchestrated si… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 63 publications
0
2
0
Order By: Relevance
“…RASopathies make up a family of diseases characterized by congenital hyperactivating mutations of the RAS/MAPK pathway. These diseases disrupt a variety of developmental processes, from gastrulation to brain and heart development. , We identified lysine 16 as the nucleotide binding lysine in the pocket (Figure A) and mutated it to an amber stop codon (K16TAG), then synthesized the corresponding mRNA through in vitro transcription . We incorporated the photocaged lysine 2 into the HA-tagged NRAS and performed Western blots to confirm the expression of the construct (Figure B).…”
Section: Results and Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…RASopathies make up a family of diseases characterized by congenital hyperactivating mutations of the RAS/MAPK pathway. These diseases disrupt a variety of developmental processes, from gastrulation to brain and heart development. , We identified lysine 16 as the nucleotide binding lysine in the pocket (Figure A) and mutated it to an amber stop codon (K16TAG), then synthesized the corresponding mRNA through in vitro transcription . We incorporated the photocaged lysine 2 into the HA-tagged NRAS and performed Western blots to confirm the expression of the construct (Figure B).…”
Section: Results and Discussionmentioning
confidence: 99%
“… 74 , 76 78 We identified lysine 16 as the nucleotide binding lysine in the pocket ( Figure 6 A) 79 and mutated it to an amber stop codon (K16TAG), then synthesized the corresponding mRNA through in vitro transcription. 80 We incorporated the photocaged lysine 2 into the HA-tagged NRAS and performed Western blots to confirm the expression of the construct ( Figure 6 B). No background amber suppression was seen in the no UAA control, and a band at the same molecular weight as the non-TAG control was seen in the presence of 2 , confirming caged NRAS expression.…”
Section: Results and Discussionmentioning
confidence: 99%